Zobrazeno 1 - 10
of 12
pro vyhledávání: '"KR Raveendra"'
Autor:
KR Raveendra, CN Mohan
Publikováno v:
APIK Journal of Internal Medicine, Vol 9, Iss 2, Pp 94-98 (2021)
Background and Objectives: Organophosphate compounds are frequently used for homicidal and suicidal purposes, organophosphates account for as many as 80% of pesticide-related hospital admissions. This study was done to estimate serum amylase and plas
Autor:
Binay K Thakur, Sandeep N. Athalye, Rahul Darnule, Ashwani Marwah, Sarika Deodhar, Nitin M Chaudhari, Chirag Rathod, A Radhika, Sivakumar Vaidyanathan, KR Raveendra, Subramanian Loganathan
ObjectiveTo evaluate safety and efficacy of Itolizumab in hospitalized COVID-19 patients with PaO2/FiO2 ratio (PFR) ≤200 requiring oxygen therapy.DesignA multicentre, single-arm, Phase-4 study with a treatment period of 30-Days and an extended foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e741e81f686961e81411288c2d79e8d1
https://doi.org/10.1101/2021.10.25.21265462
https://doi.org/10.1101/2021.10.25.21265462
Autor:
KR, Raveendra, Rathod, Chirag, Darnule, Rahul, Loganathan, Subramanian, Deodhar, Sarika, A, Radhika, Marwah, Ashwani, Chaudhari, Nitin M, Thakur, Binay K, Vaidyanathan, Sivakumar, Athalye, Sandeep Nilkanth
Publikováno v:
Expert Opinion on Biological Therapy; May 2023, Vol. 23 Issue: 5 p443-454, 12p
Publikováno v:
APIK Journal of Internal Medicine, Vol 8, Iss 4, Pp 203-205 (2020)
Tuberculosis, both pulmonary and extrapulmonary, is a procoagulant state, which can lead to deep-vein thrombosis and thromboembolism. Rifampicin, the antitubercular drug by itself, can cause a procoagulant state. Here, we describe the case of a patie
Autor:
KR Raveendra, ShubhaVishnu Hegde
Publikováno v:
APIK Journal of Internal Medicine. 6:18
Autor:
KR Raveendra, KR Divya Sharma
Publikováno v:
APIK Journal of Internal Medicine. 5:36
Autor:
Jananee Muralidharan, KR Raveendra
Publikováno v:
APIK Journal of Internal Medicine. 4:48
Autor:
Dravid AN; Department of Medicine, Poona Hospital and Research Centre, Maharashtra, India., Pilawan AS; Department of Medicine, Government Medical College & Hospital, Maharashtra, India., Anuradha S; Department of Medicine, Maulana Azad Medical College, New Delhi, India., Morkar DN; Department of Medicine, KLE Hospital, Karnataka, India., Ramapuram JT; Department of Medicine, Kasturba Medical College, Karnataka, India., Madhukarrao KM; Department of Medicine, Sahyadri Specialty Hospital, Maharashtra, India., Naik KS; Department of Medicine, Rajiv Gandhi Institute of Medical Science and RIMS Government General Hospital, Andhra Pradesh, India., Bhrusundi M; Department of Medicine, NKP Salve Institute of Medical Sciences and Late Mangeshkar Hospital, Maharashtra, India., Raveendra KR; Department of Medicine, Bangalore Medical College and Research Institute, Karnataka, India., Nageswaramma S; Department of Dermatology, Guntur Government General Hospital, Andhra Pradesh, India., Kulkarni V; Department of Dermatology, Deenanath Mangeshkar Hospital and Research Centre, Maharashtra, India.
Publikováno v:
Medicine [Medicine (Baltimore)] 2023 Nov 03; Vol. 102 (44), pp. e35643.
Autor:
Kr R; Department of Medicine, Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India., Rathod C; Department of Medicine, GMERS Medical College & Hospital, Old TB Hospital Campus, Vadodara, Gujarat, India., Darnule R; Department of Medicine, Saint George's Hospital, Mumbai, Maharashtra, India., Loganathan S; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., Deodhar S; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., A R; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., Marwah A; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., Chaudhari NM; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., Thakur BK; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., Vaidyanathan S; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India., Athalye SN; Clinical Development and Medical Affairs, Biocon Biologics Limited, Bengaluru, Karnataka, India.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2023 May; Vol. 23 (5), pp. 443-454. Date of Electronic Publication: 2023 Apr 28.
Autor:
Koteshwar P; Clinical Pharmacology, Institute of Clinical Research (India), Bangalore, India., Raveendra KR, Allan JJ, Goudar KS, Venkateshwarlu K, Agarwal A
Publikováno v:
Pharmacognosy magazine [Pharmacogn Mag] 2013 Oct; Vol. 9 (36), pp. 344-9.